Elite Pharmaceuticals ELTP Revenue Breakdown

OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST
Annual revenue breakdowns for Elite Pharmaceuticals, fiscal 2011 to 2026, as reported in its filings.
Annual history

Elite Pharmaceuticals Revenue by Product & Service

Years FY 2011–2026
Lines 4
FY 2026 Total $148.87M

Scheduled Products Manufacturing Fees was Elite Pharmaceuticals’s largest product and service line in fiscal 2026, bringing in $141.47M of $148.87M (95%).

Elite Pharmaceuticals revenue by product and service, fiscal 2011 to 2026
Product and Service FY 2011 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2023 FY 2024 FY 2025 FY 2026
Scheduled Products Manufacturing Fees — — $74.76M $141.47M
Unscheduled Products Manufacturing Fees — — $7.23M $6.34M
Unscheduled Products Licensing Fees — — $1.81M $594.49K
Scheduled Products Licensing Fees — — $248.79K $465.51K
Total $34.16M $56.63M $84.04M $148.87M
Totals include 7 discontinued lines from earlier reporting.

Elite Pharmaceuticals revenue by product and service: what the figures show

Elite Pharmaceuticals brought in $148.87M from its four product and service lines in fiscal 2026, the year ended March 31, 2026. That was up 77.1% from $84.04M in fiscal 2025. Scheduled Products Manufacturing Fees was the largest at $141.47M (95.0%), ahead of Unscheduled Products Manufacturing Fees at $6.34M (4.3%) and Unscheduled Products Licensing Fees at $594.49K (0.4%). The remaining line, Scheduled Products Licensing Fees, brought in $465.51K.

Compared with fiscal 2025, Scheduled Products Manufacturing Fees grew 89.2% to $141.47M, while Unscheduled Products Manufacturing Fees fell 12.2% to $6.34M.

Elite Pharmaceuticals began breaking out Scheduled Products Manufacturing Fees in fiscal 2025, Unscheduled Products Manufacturing Fees in fiscal 2025, Unscheduled Products Licensing Fees in fiscal 2025 and Scheduled Products Licensing Fees in fiscal 2025. Elite Pharmaceuticals stopped reporting Manufacturing ($54.12M in fiscal 2024) and Licensing ($2.50M in fiscal 2024) as separate lines.

Annual history

Elite Pharmaceuticals Revenue by Fees

Years FY 2020–2021
Lines 2
FY 2021 Total $25.38M

Manufacturing Fees was Elite Pharmaceuticals’s largest revenue line in fiscal 2021, bringing in $21.00M of $25.38M (83%).

Elite Pharmaceuticals revenue by fees, fiscal 2020 to 2021
Fees FY 2020 FY 2021
Manufacturing Fees $14.53M $21.00M
Licensing Fees $3.47M $4.38M
Total $17.99M $25.38M

Elite Pharmaceuticals revenue by fees: what the figures show

Elite Pharmaceuticals brought in $25.38M from its two revenue lines in fiscal 2021, the year ended March 31, 2021. That was up 41.0% from $17.99M in fiscal 2020. Manufacturing Fees was the largest at $21.00M (82.7%), ahead of Licensing Fees at $4.38M (17.3%).

Compared with fiscal 2020, Manufacturing Fees grew 44.5% to $21.00M and Licensing Fees grew 26.4% to $4.38M.

Questions

Elite Pharmaceuticals Revenue Breakdown FAQ

How does Elite Pharmaceuticals make money?

Elite Pharmaceuticals (ELTP) reports its revenue by product and service and by fees. In fiscal 2026, Scheduled Products Manufacturing Fees was its largest product and service line, bringing in $141.47M (95.0% of the total), followed by Unscheduled Products Manufacturing Fees at $6.34M (4.3%).

What is Elite Pharmaceuticals' largest product and service line?

Scheduled Products Manufacturing Fees was Elite Pharmaceuticals' largest product and service line in fiscal 2026, bringing in $141.47M, or 95.0% of the $148.87M total across its four product and service lines.

What is Elite Pharmaceuticals' largest revenue line?

Manufacturing Fees was Elite Pharmaceuticals' largest revenue line in fiscal 2021, bringing in $21.00M, or 82.7% of the $25.38M total across its two revenue lines.

Which Elite Pharmaceuticals product and service line is growing the fastest?

Scheduled Products Manufacturing Fees grew faster than Unscheduled Products Manufacturing Fees in fiscal 2026, up 89.2% from $74.76M to $141.47M. Unscheduled Products Manufacturing Fees fell 12.2% to $6.34M.

Where does this revenue breakdown data come from?

Every figure comes from Elite Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Elite Pharmaceuticals gives it, and years follow its fiscal calendar.

How far back does Elite Pharmaceuticals' revenue breakdown go?

Elite Pharmaceuticals' revenue by product and service goes back to fiscal 2011, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.